{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T13:16:05Z","timestamp":1758460565859,"version":"3.44.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"am","delay-in-days":287,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuropharm.2022.109328","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T20:42:40Z","timestamp":1667853760000},"page":"109328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5783-0759","authenticated-orcid":false,"given":"Huiping","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Kiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey M.","family":"Mabry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiroh","family":"Kishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Chuan","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"Opioid Overdose Crisis. Opioid Overdose Crisis","author":"Abuse","key":"10.1016\/j.neuropharm.2022.109328_bib1"},{"key":"10.1016\/j.neuropharm.2022.109328_bib2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2022.109328_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ejp.1675","article-title":"Medical cannabis treatment for chronic pain: outcomes and prediction of response","volume":"25","author":"Aviram","year":"2021","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2022.109328_bib4","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","article-title":"Efficacy of cannabis-based medicines for pain management: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Aviram","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2022.109328_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0376-8716(94)90011-6","article-title":"The effect of chronic naltrexone pretreatment on associative vs. non-associative morphine tolerance","volume":"36","author":"Azorlosa","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2022.109328_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2370","article-title":"Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis","volume":"3","author":"Bahji","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuropharm.2022.109328_bib7","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","article-title":"Opioid complications and side effects","volume":"11","author":"Benyamin","year":"2008","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2022.109328_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1176\/appi.ajp.2015.15020262","article-title":"Prescription opioid misuse, abuse, and treatment in the United States: an update","volume":"173","author":"Brady","year":"2016","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109328_bib9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1176\/appi.ajp.161.11.1967","article-title":"Review of the validity and significance of cannabis withdrawal syndrome","volume":"161","author":"Budney","year":"2004","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109328_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/jpet.104.068411","article-title":"Antiallodynic effects of loperamide and fentanyl against topical capsaicin-induced allodynia in unanesthetized primates","volume":"311","author":"Butelman","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib11","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1073\/pnas.1010077107","article-title":"Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons","volume":"vol. 107","author":"Cao","year":"2010","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2022.109328_bib12","first-page":"153","article-title":"Receptor and molecular targets for the development of novel opioid and non-opioid analgesic therapies","volume":"24","author":"Chen","year":"2021","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2022.109328_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0022-3565(25)12911-X","article-title":"In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity","volume":"277","author":"Compton","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/jpet.111.188540","article-title":"Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat","volume":"340","author":"Craft","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.112.194308","article-title":"Roles of mu-opioid receptors and nociceptin\/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates","volume":"343","author":"Cremeans","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib16","first-page":"246","article-title":"Physiological and psychological dependence to synthetic Delta9 tetrahydrocannabinol (thc) in rhesus monkeys","volume":"13","author":"Deneau","year":"1971","journal-title":"Pharmacologist"},{"key":"10.1016\/j.neuropharm.2022.109328_bib17","doi-asserted-by":"crossref","first-page":"E5511","DOI":"10.1073\/pnas.1605295113","article-title":"A novel orvinol analog, BU08028, as a safe opioid analgesic without abuse liability in primates","volume":"vol. 113","author":"Ding","year":"2016","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2022.109328_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar3483","article-title":"A bifunctional nociceptin and mu opioid receptor agonist is analgesic without opioid side effects in nonhuman primates","volume":"10","author":"Ding","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2022.109328_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113602","article-title":"Translational value of non-human primates in opioid research","volume":"338","author":"Ding","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2022.109328_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF00434412","article-title":"An abstinence syndrome following chronic administration of delta-9-terahydrocannabinol in rhesus monkeys","volume":"71","author":"Fredericks","year":"1980","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109328_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002130050849","article-title":"Abstinence symptoms following smoked marijuana in humans","volume":"141","author":"Haney","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2022.109328_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0091-3057(90)90421-D","article-title":"Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine","volume":"36","author":"Heishman","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109328_bib23","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.bja.2019.03.005","article-title":"Opioids: refining the perioperative role of God's own medicine","volume":"122","author":"Hewson","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2022.109328_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jama.2019.17403","article-title":"Medical cannabis","volume":"323","author":"Hill","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109328_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","article-title":"Cannabis and pain: a clinical review","volume":"2","author":"Hill","year":"2017","journal-title":"Cannabis Cannabinoid. Res."},{"key":"10.1016\/j.neuropharm.2022.109328_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","article-title":"Long-lasting antinociceptive spinal effects in primates of the novel nociceptin\/orphanin FQ receptor agonist UFP-112","volume":"148","author":"Hu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2022.109328_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109328_bib28","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jnc.15369","article-title":"Cannabis use, abuse, and withdrawal: cannabinergic mechanisms, clinical, and preclinical findings","volume":"157","author":"Kesner","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109328_bib29","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/j.bja.2018.10.065","article-title":"BU10038 as a safe opioid analgesic with fewer side-effects after systemic and intrathecal administration in primates","volume":"122","author":"Kiguchi","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2022.109328_bib30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109328_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0014-2999(00)00279-X","article-title":"Acute dependence on, but not tolerance to, heroin and morphine as measured by respiratory effects in rhesus monkeys","volume":"398","author":"Kishioka","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109328_bib32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3565(24)38146-7","article-title":"Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys","volume":"289","author":"Ko","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib33","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/jpet.105.094409","article-title":"Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey","volume":"316","author":"Ko","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ajad.12862","article-title":"Review article: effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment","volume":"28","author":"Kosten","year":"2019","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neuropharm.2022.109328_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/ALN.0b013e31817881e1","article-title":"Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers","volume":"109","author":"Kraft","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2022.109328_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7367","article-title":"Rate and risk factors associated with prolonged opioid use after surgery: a systematic review and meta-analysis","volume":"3","author":"Lawal","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.neuropharm.2022.109328_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116717","article-title":"Clinical uses of cannabis and cannabinoids in the United States","volume":"411","author":"Levinsohn","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2022.109328_bib38","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1002\/j.1552-4604.2002.tb05999.x","article-title":"Marijuana withdrawal syndrome in the animal model","volume":"42","author":"Lichtman","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109328_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejp.1148","article-title":"Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings","volume":"22","author":"Lotsch","year":"2018","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2022.109328_bib40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s40263-019-00660-0","article-title":"Opioid-induced tolerance and hyperalgesia","volume":"33","author":"Mercadante","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2022.109328_bib41","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"Mucke","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2022.109328_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109328_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00325481.2018.1407618","article-title":"Going beyond prescription pain relievers to understand the opioid epidemic: the role of illicit fentanyl, new psychoactive substances, and street heroin","volume":"130","author":"Pergolizzi","year":"2018","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.neuropharm.2022.109328_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ilar.52.3.295","article-title":"Marijuana dependence: not just smoke and mirrors","volume":"52","author":"Ramesh","year":"2011","journal-title":"ILAR J."},{"key":"10.1016\/j.neuropharm.2022.109328_bib45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.neuropharm.2022.109328_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2014.06.023","article-title":"JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects","volume":"740","author":"Rodriguez","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109328_bib47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11926-017-0693-1","article-title":"Cannabis and cannabinoids for chronic pain","volume":"19","author":"Romero-Sandoval","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.neuropharm.2022.109328_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neuropharm.2009.06.004","article-title":"Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-\/-) and not CB2(-\/-) mice in models of acute and persistent pain","volume":"57","author":"Sain","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109328_bib49","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.110.168435","article-title":"Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs","volume":"334","author":"Stewart","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109328_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2011.11.040","article-title":"Delta9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys","volume":"201","author":"Taffe","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2022.109328_bib51","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41380-020-0661-4","article-title":"The changing opioid crisis: development, challenges and opportunities","volume":"26","author":"Volkow","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109328_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain--misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2022.109328_bib53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vuckovic","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109328_bib54","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"73","author":"Waldhoer","year":"2004","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2022.109328_bib55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/01.anes.0000286986.92475.b7","article-title":"Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers","volume":"107","author":"Wallace","year":"2007","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2022.109328_bib56","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jpain.2015.03.008","article-title":"Efficacy of inhaled cannabis on painful diabetic neuropathy","volume":"16","author":"Wallace","year":"2015","journal-title":"J. Pain"},{"key":"10.1016\/j.neuropharm.2022.109328_bib57","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2022.109328_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209947","article-title":"Tolerance and dependence to Delta9-tetrahydrocannabinol in rhesus monkeys: activity assessments","volume":"14","author":"Wilkerson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2022.109328_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1152\/physrev.2001.81.1.299","article-title":"Cellular and synaptic adaptations mediating opioid dependence","volume":"81","author":"Williams","year":"2001","journal-title":"Physiol. Rev."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:21:03Z","timestamp":1758439263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822003872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":59,"alternative-id":["S0028390822003872"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109328","relation":{},"ISSN":["0028-3908"],"issn-type":[{"type":"print","value":"0028-3908"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109328"}}